▲ Peaking
Business
Silence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Darmstadt, Germany
Merck KGaA’s $1.3 billion bid for Silence Therapeutics signals a high‑stakes push into RNA drug platforms.
Merck Kgaa
2 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Merck Kgaa
This hub groups 2 separate news trends connected to Merck Kgaa, spanning June 25, 2026 through October 19, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 22 article observations and 20 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 holds ✗
Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets
Germany's Merck KGaA is acquiring Minneapolis-based Bio-Techne in an $11.3 billion all-cash deal to expand its life sciences reach.